Compare EVAX & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVAX | JTAI |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | Denmark | United States |
| Employees | N/A | 8 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 4.6M |
| IPO Year | 2020 | N/A |
| Metric | EVAX | JTAI |
|---|---|---|
| Price | $4.02 | $5.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $11.67 | $0.40 |
| AVG Volume (30 Days) | 29.2K | ★ 25.7M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $0.04 |
| 52 Week High | $12.15 | $4.70 |
| Indicator | EVAX | JTAI |
|---|---|---|
| Relative Strength Index (RSI) | 57.43 | 98.36 |
| Support Level | $2.70 | $3.00 |
| Resistance Level | $4.64 | N/A |
| Average True Range (ATR) | 0.33 | 0.40 |
| MACD | 0.02 | 0.36 |
| Stochastic Oscillator | 90.92 | 53.84 |
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.